The variable regions from the antibody (the extracellular domain) allow for recognition of MHC-independent structures on the surface of the target tumor cells, while the intracellular co-stimulatory and signaling domains initiate the self-renewal and lytic function of T cells upon antigen binding. This evidence concerns the gene HLA-C and neoplasm.